Lennart Lenk

10PUBLICATIONS
66CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 19, 2026
Complementary efficacy of CD127-directed immunotherapy with lusvertikimab and ABL-targeting tyrosine kinase inhibitors in preclinical ABL-class-fusion-positive B-ALL.

|Jun 01, 2026
Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia.

|Apr 20, 2026
Biological and clinical characteristics of ETV6::RUNX1-like ALL.

|Mar 13, 2026
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.

Johanna M Horns, Thomas Beder, Axel Künstner

|Feb 26, 2026
Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups.

Alina M Hartmann, Lorenz Bastian, Malwine J Barz

|Jul 15, 2024
A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALL.

Philip Gebing, Stefanos Loizou, Sebastian Hänsch

Pageof 2

Frequent Collaborators

4 joint publications

Lorenz Bastian

3 joint publications

Denis Martin Schewe

2 joint publications

Željko Antić

2 joint publications

Martin Schrappe